Methionine-enkephalin concentrations correlate with stage of disease but not pruritus in patients with primary biliary cirrhosis

J. R. Spivey, R. A. Jorgensen, Gregory James Gores, K. D. Lindor

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Objective: Opiate antagonist agents ameliorate pruritus in some patients with cholestatic liver disease, suggesting that endogenous opioids may mediate pruritus in cholestasis. However, the endogenous opioids potentially responsible for pruritus remain unknown. Methionine-enkephalin is an endogenous opioid synthesized in numerous tissues including the gastrointestinal tract, and released into the portal circulation. Serum methionine-enkephalin concentrations are elevated in patients with chronic liver disease, making this opioid a candidate for opioid-mediated pruritus in cholestatic liver disease. The aim of our study was to determine whether elevated circulating methionine-enkephalin concentrations are associated with pruritus. Methods: Serum concentrations of methionine-enkephalin were measured in 54 consecutive, untreated patients with primary biliary cirrhosis and 20 healthy controls. There was a direct correlation between methionine- enkephalin concentrations and total serum bilirubin (r = 0.42, p < 0.05) and the Mayo risk score (r = 0.5, p < 0.005). Methionine-enkephalin concentrations were significantly higher in histological stages 3 and 4 (48 ± 4 pg/ml, n = 44), compared with stages 1 and 2 (29 ± 12 pg/ml, n = 10, p < 0.05). Methionine-enkephalin concentrations in both histological groups were significantly higher than those in 20 healthy controls (16 ± 4 pg/ml, p < 0.005). Results: There was no significant correlation between methionine- enkephalin concentrations and the presence of pruritus (46 ± 25 pg/ml with pruritus vs. 40 ± 22 pg/ml without pruritus, n = 20). Conclusions: Increased serum methionine-enkephalin concentrations in patients with primary biliary cirrhosis were not associated with pruritus.

Original languageEnglish (US)
Pages (from-to)2028-2032
Number of pages5
JournalAmerican Journal of Gastroenterology
Volume89
Issue number11
StatePublished - 1994

Fingerprint

Methionine Enkephalin
Biliary Liver Cirrhosis
Pruritus
Opioid Analgesics
Liver Diseases
Serum
Opiate Alkaloids
Cholestasis
Bilirubin
Gastrointestinal Tract
Chronic Disease

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Methionine-enkephalin concentrations correlate with stage of disease but not pruritus in patients with primary biliary cirrhosis. / Spivey, J. R.; Jorgensen, R. A.; Gores, Gregory James; Lindor, K. D.

In: American Journal of Gastroenterology, Vol. 89, No. 11, 1994, p. 2028-2032.

Research output: Contribution to journalArticle

@article{b70e2185a91344beafdbdeb858717d34,
title = "Methionine-enkephalin concentrations correlate with stage of disease but not pruritus in patients with primary biliary cirrhosis",
abstract = "Objective: Opiate antagonist agents ameliorate pruritus in some patients with cholestatic liver disease, suggesting that endogenous opioids may mediate pruritus in cholestasis. However, the endogenous opioids potentially responsible for pruritus remain unknown. Methionine-enkephalin is an endogenous opioid synthesized in numerous tissues including the gastrointestinal tract, and released into the portal circulation. Serum methionine-enkephalin concentrations are elevated in patients with chronic liver disease, making this opioid a candidate for opioid-mediated pruritus in cholestatic liver disease. The aim of our study was to determine whether elevated circulating methionine-enkephalin concentrations are associated with pruritus. Methods: Serum concentrations of methionine-enkephalin were measured in 54 consecutive, untreated patients with primary biliary cirrhosis and 20 healthy controls. There was a direct correlation between methionine- enkephalin concentrations and total serum bilirubin (r = 0.42, p < 0.05) and the Mayo risk score (r = 0.5, p < 0.005). Methionine-enkephalin concentrations were significantly higher in histological stages 3 and 4 (48 ± 4 pg/ml, n = 44), compared with stages 1 and 2 (29 ± 12 pg/ml, n = 10, p < 0.05). Methionine-enkephalin concentrations in both histological groups were significantly higher than those in 20 healthy controls (16 ± 4 pg/ml, p < 0.005). Results: There was no significant correlation between methionine- enkephalin concentrations and the presence of pruritus (46 ± 25 pg/ml with pruritus vs. 40 ± 22 pg/ml without pruritus, n = 20). Conclusions: Increased serum methionine-enkephalin concentrations in patients with primary biliary cirrhosis were not associated with pruritus.",
author = "Spivey, {J. R.} and Jorgensen, {R. A.} and Gores, {Gregory James} and Lindor, {K. D.}",
year = "1994",
language = "English (US)",
volume = "89",
pages = "2028--2032",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Methionine-enkephalin concentrations correlate with stage of disease but not pruritus in patients with primary biliary cirrhosis

AU - Spivey, J. R.

AU - Jorgensen, R. A.

AU - Gores, Gregory James

AU - Lindor, K. D.

PY - 1994

Y1 - 1994

N2 - Objective: Opiate antagonist agents ameliorate pruritus in some patients with cholestatic liver disease, suggesting that endogenous opioids may mediate pruritus in cholestasis. However, the endogenous opioids potentially responsible for pruritus remain unknown. Methionine-enkephalin is an endogenous opioid synthesized in numerous tissues including the gastrointestinal tract, and released into the portal circulation. Serum methionine-enkephalin concentrations are elevated in patients with chronic liver disease, making this opioid a candidate for opioid-mediated pruritus in cholestatic liver disease. The aim of our study was to determine whether elevated circulating methionine-enkephalin concentrations are associated with pruritus. Methods: Serum concentrations of methionine-enkephalin were measured in 54 consecutive, untreated patients with primary biliary cirrhosis and 20 healthy controls. There was a direct correlation between methionine- enkephalin concentrations and total serum bilirubin (r = 0.42, p < 0.05) and the Mayo risk score (r = 0.5, p < 0.005). Methionine-enkephalin concentrations were significantly higher in histological stages 3 and 4 (48 ± 4 pg/ml, n = 44), compared with stages 1 and 2 (29 ± 12 pg/ml, n = 10, p < 0.05). Methionine-enkephalin concentrations in both histological groups were significantly higher than those in 20 healthy controls (16 ± 4 pg/ml, p < 0.005). Results: There was no significant correlation between methionine- enkephalin concentrations and the presence of pruritus (46 ± 25 pg/ml with pruritus vs. 40 ± 22 pg/ml without pruritus, n = 20). Conclusions: Increased serum methionine-enkephalin concentrations in patients with primary biliary cirrhosis were not associated with pruritus.

AB - Objective: Opiate antagonist agents ameliorate pruritus in some patients with cholestatic liver disease, suggesting that endogenous opioids may mediate pruritus in cholestasis. However, the endogenous opioids potentially responsible for pruritus remain unknown. Methionine-enkephalin is an endogenous opioid synthesized in numerous tissues including the gastrointestinal tract, and released into the portal circulation. Serum methionine-enkephalin concentrations are elevated in patients with chronic liver disease, making this opioid a candidate for opioid-mediated pruritus in cholestatic liver disease. The aim of our study was to determine whether elevated circulating methionine-enkephalin concentrations are associated with pruritus. Methods: Serum concentrations of methionine-enkephalin were measured in 54 consecutive, untreated patients with primary biliary cirrhosis and 20 healthy controls. There was a direct correlation between methionine- enkephalin concentrations and total serum bilirubin (r = 0.42, p < 0.05) and the Mayo risk score (r = 0.5, p < 0.005). Methionine-enkephalin concentrations were significantly higher in histological stages 3 and 4 (48 ± 4 pg/ml, n = 44), compared with stages 1 and 2 (29 ± 12 pg/ml, n = 10, p < 0.05). Methionine-enkephalin concentrations in both histological groups were significantly higher than those in 20 healthy controls (16 ± 4 pg/ml, p < 0.005). Results: There was no significant correlation between methionine- enkephalin concentrations and the presence of pruritus (46 ± 25 pg/ml with pruritus vs. 40 ± 22 pg/ml without pruritus, n = 20). Conclusions: Increased serum methionine-enkephalin concentrations in patients with primary biliary cirrhosis were not associated with pruritus.

UR - http://www.scopus.com/inward/record.url?scp=0028051829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028051829&partnerID=8YFLogxK

M3 - Article

C2 - 7942730

AN - SCOPUS:0028051829

VL - 89

SP - 2028

EP - 2032

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 11

ER -